January 12, 2012 — UT-Southwestern Medical Center in Dallas, Texas, has acquired and installed a high-resolution positron emission tomography (PET) scanner - produced by Naviscan, Inc. - the breast application for Positron Emission Mammography (PEM). The scanner will be used both for clinical patients as well as for research focused on lowering radiation dose and novel radiotracers. UT-Southwestern ranks among the top academic medical centers in the world and was ranked as the best hospital in Dallas by U.S. News & World Report in 2011.

PEM imaging shows the location as well as the metabolic phase of a lesion. This information is critical in determining whether a lesion is malignant and influences the course of treatment by providing an ability to distinguish between benign and malignant lesions, what researchers term “specificity.” Recent studies have demonstrated that PEM has similar sensitivity and higher specificity than breast magnetic resonance imaging (MRI). The scanner is the only FDA-cleared, CE-certified 3-D Molecular Breast Imaging (MBI) device on the market with biopsy-guidance.

For more information: www.naviscan.com


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Breast Imaging

April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...

Time April 02, 2024
arrow
News | Breast Imaging

March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...

Time March 20, 2024
arrow
News | Breast Imaging

March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...

Time March 15, 2024
arrow
News | Breast Imaging

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | Breast Imaging

February 9, 2024 — An innovative breast imaging technique provides high sensitivity for detecting cancer while ...

Time February 09, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
Feature | PET-CT | By Melinda Taschetta-Millane

According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...

Time January 17, 2024
arrow
News | Prostate Cancer

January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...

Time January 05, 2024
arrow
Subscribe Now